Use of B-type natriuretic peptide in critically ill patients

Biomarkers in Medicine

Volumn 3, Issue 5, 2009, Pages 541-547

  Pirracchio, Romain ^a   Salem, Reda ^a   Mebazaa, Alexandre ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Biomarkers; BNP; Pulmonary edema; Pulmonary embolism; Respiratory failure

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; MEMBRANE METALLOENDOPEPTIDASE;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COR PULMONALE; CRITICALLY ILL PATIENT; DIAGNOSTIC VALUE; DYSPNEA; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HUMAN; INTENSIVE CARE; LUNG EDEMA; LUNG EMBOLISM; PERIOPERATIVE COMPLICATION; PROGNOSIS; RESPIRATORY FAILURE; REVIEW; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK;

EID: 70450286284     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/bmm.09.45     Document Type: Review

References (53)

1. Iwanaga Y, Nishi I, Furuichi S et al.: B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J. Am. Coll. Cardiol. 47(4), 742-748 (2006). (Pubitemid 43243094)
2. Stein BC, Levin RI: Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am. Heart J. 135(5 Pt 1), 914-923 (1998).
3. van Kimmenade RR, Januzzi JL Jr, Bakker JA et al.: Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J. Am. Coll. Cardiol. 53(10), 884-890 (2009).
4. Schou M, Alehagen U, Goetze JP, Gustafsson F, Dahlstrom U: Effect of estimated glomerular filtration rate on plasma concentrations of B-type natriuretic peptides measured with multiple immunoassays in elderly individuals. Heart 95, 1514-1519 (2009).
5. Mueller C, Breidthardt T, Laule-Kilian K, Christ M, Perruchoud AP: The integration of BNP and NT-proBNP into clinical medicine. Swiss Med. Wkly 137(1-2), 4-12 (2007). (Pubitemid 46191225)
6. Maisel AS, Krishnaswamy P, Nowak RM et al.: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 347(3), 161-167 (2002).
7. McLean AS, Tang B, Nalos M, Huang SJ, Stewart DE: Increased B-type natriuretic peptide (BNP) level is a strong predictor for cardiac dysfunction in intensive care unit patients. Anaesth. Inten. Care 31(1), 21-27 (2003). (Pubitemid 36267314)
8. Charpentier J, Luyt CE, Fulla Y et al.: Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit. Care Med. 32(3), 660-665 (2004). (Pubitemid 38340060)
9. Roch A, Allardet-Servent J, Michelet P et al.: NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit. Care Med. 33(5), 1001-1007 (2005). (Pubitemid 40638172)
10. Karmpaliotis D, Kirtane AJ, Ruisi CP et al.: Diagnostic and prognostic utility of brain natriuretic peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema. Chest 131(4), 964-971 (2007). (Pubitemid 46608693)
11. Kucher N, Goldhaber SZ: Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 108(18), 2191-2194 (2003).
12. Grabowski M, Filipiak KJ, Malek LA et al.: Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty. Int. J. Cardiol. 115(3), 386-390 (2007). (Pubitemid 46185640)
13. McLean AS, Huang SJ, Hyams S et al.: Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock. Crit. Care Med. 35(4), 1019-1026 (2007). ■■ Shows that increased B-type natriuretic peptide (BNP) in septic shock is not necessarily associated with impaired heart function.
14. Ware LB, Matthay MA: Clinical practice. Acute pulmonary edema. N. Engl. J. Med. 353(26), 2788-2796 (2005).
15. Maeder M, Ammann P, Rickli H, Diethelm M: Elevation of B-type natriuretic peptide levels in acute respiratory distress syndrome. Swiss Med. Wkly 133(37-38), 515-518 (2003). (Pubitemid 37486392)
16. Jefic D, Lee JW, Jefic D, Savoy-Moore RT, Rosman HS: Utility of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients. Chest 128(1), 288-295 (2005). (Pubitemid 40994486)
17. Bal L, Thierry S, Brocas E et al.: B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress. Acta Anaesthesiol. Scand. 50(3), 340-347 (2006).
18. Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP: Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J. Am. Coll. Cardiol. 45(10), 1667-1671 (2005).
19. Rana R, Vlahakis NE, Daniels CE et al.: B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema. Crit. Care Med. 34(7), 1941-1946 (2006).
20. Levitt JE, Vinayak AG, Gehlbach BK et al.: Diagnostic utility of B-type natriuretic peptide in critically ill patients with pulmonary edema: a prospective cohort study. Crit. Care 12(1), R3 (2008).
21. Thierry S, Lecuyer L, Brocas E et al.: Interest of the brain natriuretic peptide as a marker of acute cor pulmonale in acute respiratory distress syndrome. Ann. Fr. Anesth. Reanim. 25(8), 815-819 (2006).
22. Bando M, Ishii Y, Sugiyama Y, Kitamura S: Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale. Respir. Med. 93(7), 507-514 (1999). (Pubitemid 29364066)
23. Wiedemann HP, Wheeler AP, Bernard GR et al.: Comparison of two fluid-management strategies in acute lung injury. N. Engl. J. Med. 354(24), 2564-2575 (2006).
24. Abroug F, Ouanes-Besbes L, Nciri N et al.: Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am. J. Respir. Crit. Care Med. 174(9), 990-996 (2006). (Pubitemid 44684447)
25. Januzzi JL Jr, Camargo CA, Anwaruddin S et al.: The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am. J. Cardiol. 95(8), 948-954 (2005). (Pubitemid 40487743)
26. Stolz D, Breidthardt T, Christ-Crain M et al.: Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of chronic obstructive pulmonary disease. Chest 133(5), 1088-1094 (2008).
27. Lemaire F, Teboul JL, Cinotti L et al.: Acute left ventricular dysfunction during unsuccessful weaning from mechanical ventilation. Anesthesiology 69(2), 171-179 (1988).
28. Mekontso-Dessap A, de Prost N, Girou E et al.: B-type natriuretic peptide and weaning from mechanical ventilation. Intensive Care Med. 32(10), 1529-1536 (2006).
29. Chien JY, Lin MS, Huang YC, Chien YF, Yu CJ, Yang PC: Changes in B-type natriuretic peptide improve weaning outcome predicted by spontaneous breathing trial. Crit. Care Med. 36(5), 1421-1426 (2008). ■■ Shows that BNP is very helpful when weaning patients off ventilators.
30. Ait-Oufella H, Tharaux PL, Baudel JL et al.: Variation in natriuretic peptides and mitral flow indexes during successful ventilatory weaning: a preliminary study. Intensive Care Med. 33(7), 1183-1186 (2007). (Pubitemid 47036878)
31. Witthaut R, Busch C, Fraunberger P et al.: Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med. 29(10), 1696-1702 (2003). (Pubitemid 37373812)
32. Pirracchio R, Deye N, Lukaszewicz AC et al.: Impaired plasma B-type natriuretic peptide clearance in human septic shock. Crit. Care Med. 36(9), 2542-2546 (2008). ■■ Shows that increased BNP in septic shock could be explained by an alteration in one of the BNP clearance pathways.
33. Tung RH, Garcia C, Morss AM et al.: Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit. Care Med. 32(8), 1643-1647 (2004). (Pubitemid 39050512)
34. Januzzi JL, Morss A, Tung R et al.: Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study. Crit. Care 10(1), R37 (2006). (Pubitemid 47079784)
35. Rudiger A, Gasser S, Fischler M, Hornemann T, von Eckardstein A, Maggiorini M: Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit. Care Med. 34(8), 2140-2144 (2006). (Pubitemid 44305617)
36. Nikolaou NI, Goritsas C, Dede M et al.: Brain natriuretic peptide increases in septic patients without severe sepsis or shock. Eur. J. Intern. Med. 18(7), 535-541 (2007). (Pubitemid 47625954)
37. Shor R, Rozenman Y, Bolshinsky A et al.: BNP in septic patients without systolic myocardial dysfunction. Eur. J. Intern. Med. 17(8), 536-540 (2006). (Pubitemid 44827713)
38. Tanaka T, Kanda T, Takahashi T, Saegusa S, Moriya J, Kurabayashi M: Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes. J. Int. Med. Res. 32(1), 57-61 (2004). (Pubitemid 38159231)
39. Ma KK, Ogawa T, de Bold AJ: Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J. Mol. Cell. Cardiol. 36(4), 505-513 (2004).
40. He Q, LaPointe MC: Interleukin-1b regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. Hypertension 33(1 Pt 2), 283-289 (1999). (Pubitemid 29065673)
41. Mekontso-Dessap A, Tual L, Kirsch M et al.: B-type natriuretic peptide to assess haemodynamic status after cardiac surgery. Br. J. Anaesth. 97(6), 777-782 (2006). (Pubitemid 44823661)
42. Logeart D, Lecuyer L, Thabut G et al.: Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism. Intensive Care Med. 33(2), 286-292 (2007). (Pubitemid 46221234)
43. Pieralli F, Olivotto I, Vanni S et al.: Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am. J. Cardiol. 97(9), 1386-1390 (2006).
44. Kruger S, Graf J, Merx MW et al.: Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am. Heart J. 147(1), 60-65 (2004).
45. Klok FA, Mos IC, Huisman MV: Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis. Am. J. Respir. Crit. Care Med. 178(4), 425-430 (2008).
46. Lega JC, Lacasse Y, Lakhal L, Provencher S: Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis. Thorax doi: 10.1136/thx.2008.110965 (2009) (Epub ahead of print)].
47. Jarai R, Fellner B, Haoula D et al.: Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels. Crit. Care Med. 37(6), 1837-1844 (2009).
48. Brueckmann M, Huhle G, Lang S et al.: Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 112(4), 527-534 (2005). (Pubitemid 41060793)
49. Shah KB, Nolan MM, Rao K et al.: The characteristics and prognostic importance of NT-ProBNP concentrations in critically ill patients. Am. J. Med. 120(12), 1071-1077 (2007). (Pubitemid 350166230)
50. Meyer B, Huelsmann M, Wexberg P et al.: N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Crit. Care Med. 35(10), 2268-2273 (2007). (Pubitemid 47476222)
51. Hutfless R, Kazanegra R, Madani M et al.: Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J. Am. Coll. Cardiol. 43(10), 1873-1879 (2004).
52. Pedrazzini GB, Masson S, Latini R et al.: Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis. Am. J. Cardiol. 102(6), 749-754 (2008).
53. Roques F, Michel P, Goldstone AR, Nashef SA: The logistic EuroSCORE. Eur. Heart J. 24(9), 881-882 (2003).